减脂不减肌！小分子疗法迈入3期临床试验
QUALITY是一项多中心、双盲、安慰剂对照的随机、剂量探索2b期研究，旨在评估enobosarm（3 mg和6 ...
wap.stockstar14 天
CEO of LaSense Technology : Guangdong leads China in development of new quality productive ...
（原标题：CEO of LaSense Technology : Guangdong leads China in development of new quality productive forces） ...